8.3
ミカエリス-メンテン式は、薬物代謝における容量制限動態を説明する基本モデルです。この方程式は、Vmax と KM を重要なパラメータとして、血漿薬物濃度 Cp の経時的な低下率に関する洞察を提供します。
Vmax は達成可能な最大プロセス速度を表し、ミカエリス定数として知られる KM は、プロセス速…
Michaelis-Menten方程式は、薬物代謝における容量制限のある動態を表しています。
これは、VmaxとKMを主要なパラメータとして、薬物濃度の経時的な低下速度を決定します。
Vmaxは最大処理速度であり、MIMはMichaelis定数であり、この最大速度の半分の薬物濃度を示しています。
血漿薬物濃度であるKMとCPの関係に基づいて、3つのシナリオが発生します。
KMがCPに等しい場合、処理速度は最大値の半分になります。
KMがC pより大きい場合、処理速度は、通常、治療レベルのほとんどの薬物で一次排泄を模倣します。
KMがCpより小さい場合、プロセスはゼロ次消去法と同様に一定のレートを維持します。サリチル酸塩やフェニトインなどの特定の薬物は、治療用量を上昇させると、ゼロ次動態に従って肝臓の混合機能オキシダーゼを飽和させます。
Michaelis-Mentenプロットは、集中による最初の線形速度の増加、高濃度での混合順序への移行、そして最終的にVmaxでプラトーに達することを示しています。
View the full transcript and gain access to JoVE Core videos
Q1: What do Vmax and KM represent in the Michaelis-Menten equation?
Vmax is the maximum process rate at which drug metabolism occurs, representing the saturation point of metabolic enzymes. KM, the Michaelis constant, indicates the drug concentration at which the process rate reaches half its maximum value. Together, these parameters define the capacity-limited kinetics of drug elimination.
Q2: How does drug concentration affect elimination rate in nonlinear pharmacokinetics?
When drug concentration (Cp) is much lower than KM, elimination follows first-order kinetics, with rate proportional to concentration. As Cp approaches and exceeds KM, kinetics transition to mixed-order, then zero-order elimination at high concentrations. At zero-order, the elimination rate becomes constant and independent of drug concentration.
Q3: Why do certain drugs like phenytoin and salicylates show different kinetics at higher doses?
At therapeutic doses, phenytoin and salicylates follow first-order elimination. However, at elevated doses, these drugs saturate hepatic mixed-function oxidases, the enzymes responsible for their metabolism. This saturation shifts their kinetics to zero-order elimination, where the metabolic rate plateaus regardless of further dose increases.
Q4: What does the Michaelis-Menten plot reveal about drug metabolism?
The Michaelis-Menten plot illustrates how elimination rate changes with drug concentration. It shows an initial linear increase at low concentrations, transitions to mixed-order kinetics at intermediate concentrations, and reaches a plateau at Vmax. This graphical representation demonstrates the shift from first-order to zero-order elimination patterns.
Q5: What is the relationship between KM, Cp, and process rate?
When KM equals Cp, the process rate operates at exactly half its maximum capacity. If KM exceeds Cp, the process mimics first-order elimination typical of most drugs at therapeutic levels. Conversely, when KM is less than Cp, the process maintains a constant rate similar to zero-order elimination.
Q6: How does capacity-limited kinetics differ from linear drug elimination?
Capacity-limited kinetics, described by the Michaelis-Menten equation, accounts for enzyme saturation during drug metabolism. Unlike linear first-order kinetics where elimination rate is always proportional to concentration, capacity-limited kinetics show variable elimination rates depending on whether metabolic enzymes are saturated or unsaturated.
Q7: When does the Michaelis-Menten equation apply to drug metabolism?
The Michaelis-Menten equation applies when drug metabolism is limited by enzyme capacity rather than drug availability. This occurs particularly with drugs that saturate hepatic enzymes at therapeutic or elevated doses. Understanding when this equation applies helps predict how elimination rate changes across different dose ranges and plasma concentrations.